Skip to main content
logo
Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,477,000
-24,000 (-1.60%)
At close: Sep 3, 2026

Samsung Biologics Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,121,2194,556,9723,497,1463,694,5893,001,2951,568,007
Revenue Growth
50.31%30.30%-5.34%23.10%91.41%34.62%
Gross Profit
2,776,1802,500,8411,699,0531,794,5091,460,769723,350
Operating Income
2,328,9762,069,2211,321,3661,113,680983,627537,309
Net Income
1,984,3121,784,3521,083,316857,691798,056393,589
Earnings Per Share
45556.4040941.4923402.3318528.2717577.119146.19
EPS Growth
64.00%74.95%26.31%5.41%92.18%63.33%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product
4,416,3664,358,2563,380,4313,402,9832,788,7071,441,997
Other
130,457198,716116,715291,605212,588126,010

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,212,9381,485,0831,331,2892,056,2763,193,5371,371,435
Total Debt
1,241,275927,0941,486,2391,909,3332,514,0331,292,747
Net Cash (Debt)
971,664557,989-154,951146,943679,50478,688
Net Cash Growth
328.40%---78.38%763.54%17.19%
Net Cash Per Share
22307.7412802.91-3347.323174.3414965.871828.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,433,9352,247,8071,659,2551,666,229953,048454,596
Capital Expenditures
-805,580-1,391,741-1,303,573-995,071-956,840-406,254
Free Cash Flow
1,628,355856,067355,682671,158-3,79248,343
Free Cash Flow Growth
256.70%140.68%-47.01%---22.56%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.21%54.88%48.58%48.57%48.67%46.13%
Operating Margin
45.48%45.41%37.78%30.14%32.77%34.27%
Pretax Margin
48.08%46.49%39.60%30.31%33.62%35.80%
Profit Margin
38.75%39.16%30.98%23.21%26.59%25.10%
FCF Margin
31.80%18.79%10.17%18.17%-0.13%3.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
34.7943.9762.3563.0773.22151.80
Forward PE
33.1742.2162.1860.0882.37112.20
P/FCF Ratio
41.9491.66189.9080.60-1235.91
PS Ratio
13.3417.2219.3114.6419.4738.10